Alexei Basnakian received his PhD and DSc degrees from the Russian Academy of Medical Science, both in the field of DNA-degrading enzymes. He had postdoctoral trainings in molecular biology at the Harvard Medical School and in toxicology/cancer research at the National Center for Toxicological Research/U.S. Food and Drug Administration. Dr. Basnakian is a tenured Professor at the Department of Pharmacology and Toxicology, and Director of the DNA Damage and Toxicology Core Center at the University of Arkansas for Medical Sciences, and Research Career Scientist at the Veterans Hospital in Little Rock, Arkansas, USA. He is an author of 86 peer-reviewed papers and 14 reviews or book chapters. Dr. Basnakian is an Editorial Board member of several biomedical journals, and a member of NIH, AHA and VA grant study sections. His research interests are in DNases/endonucleases and DNA damage associated with toxicity, anti-cancer therapy, tissue injury and cell death.
DNases/endonucleases and DNA damage associated with toxicity, anti-cancer therapy, tissue injury and cell death.
Tatsuya TAKAGI has completed his Ph.D. at the age of 32 from Osaka University. At that time, he had been an Assistant Professor of School of Pharmaceutical Sciences, Osaka University for 5 years. Then, since 1993, he had worked for the Genome Information Research Center, Osaka University as an Associate Professor until he became a Professor of Graduate School of Pharmaceutical Sciences, Osaka University in 1998. He has published more than 150 papers in reputed journals and had served as Chairman of Division of Structure-Activity Relationship of the Pharmaceutical Society of Japan for three years (until March 2017)
Development or Revision of Computer Intensive Statistical Method for Pharmaceutical and Environmental Sciences; Application of Data Minig Method to Pharmaceutical and Environmental Sciences; Structure Based Drug Design for Infectional Diseases